| Patent application number | Description | Published |
|---|
| 20080294086 | Method and apparatus for delivering oxygen and/or other gases to tissue - A system comprising: a hollow tube having a distal end, a proximal end, and a lumen extending between the distal end and the proximal end; at least a portion of the tube comprising a porous membrane; and a gas-rich perfluorocarbon solution incorporated in the porous membrane; wherein the porous membrane has a porosity in the range of 0.001-200 microns, in order that: (i) the gas-rich perfluorocarbon solution is effectively incorporated into the porous membrane; and (ii) when the porous membrane is positioned in blood, the gas-rich perfluorocarbon solution elutes out of the porous membrane, in aggregations small enough to prevent the creation of embolisms in the blood, with the elution of the gas-rich perfluorocarbon solution into the blood varying between minutes and several hours, depending on the temperature and the hemodynamics of the blood. | 11-27-2008 |
| 20090054878 | Introduction device for a medical instrument - The invention relates to a device for introducing a medical instrument into a closed container ( | 02-26-2009 |
| 20090076449 | COATING AND METHOD FOR APPLYING A COATING TO A MEDICAL INSTRUMENT, AND MEDICAL INSTRUMENT - The invention relates to a cover ( | 03-19-2009 |
| 20090216200 | System for Introducing an Agent Into a Blood Vessel - The present invention relates to a system for introduction of an agent into a blood vessel (G), wherein the system ( | 08-27-2009 |
| 20090326508 | METHOD AND APPARATUS FOR DELIVERING OXYGEN AND/OR OTHER GASES AND/OR PHARMACOLOGICAL AGENTS TO TISSUE - A system comprising:
| 12-31-2009 |
| 20100217227 | METHOD AND APPARATUS FOR DELIVERING OXYGEN AND/OR OTHER GASES AND/OR PHARMACOLOGICAL AGENTS TO TISSUE AND MEDICAL WIRE FOR USE WITHIN THE BODY - A system comprising: a hollow tube having a distal end, a proximal end, and a lumen extending between the distal end and the proximal end; at least a portion of the tube comprising a porous membrane; and a gas-rich perfluorocarbon solution incorporated in the porous membrane; wherein the porous membrane has a porosity in the range of 0.001-200 microns, in order that: (i) the gas-rich perfluorocarbon solution is effectively incorporated into the porous membrane; and (ii) when the porous membrane is positioned in blood, the gas-rich perfluorocarbon solution elutes out of the porous membrane, in aggregations small enough to prevent the creation of embolisms in the blood, with the elution of the gas-rich perfluorocarbon solution into the blood varying between minutes and several hours, depending on the temperature and the hemodynamics of the blood. | 08-26-2010 |
